サンプル依頼リスト カート
  • English
  • Korean
表紙：フェンタニルの世界市場規模調査・予測：投与経路別、エンドユーザー別、地域別分析、2023-2030年
市場調査レポート
商品コード
1381823

フェンタニルの世界市場規模調査・予測：投与経路別、エンドユーザー別、地域別分析、2023-2030年

Global Fentanyl Market Size study & Forecast, by Route of Administration (Sublingual Tablet, Buccal Tablet, Oral Film, and Others), by End User (Hospital, Oncology Centers, Surgical Centers, and Others) and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
フェンタニルの世界市場規模調査・予測：投与経路別、エンドユーザー別、地域別分析、2023-2030年
出版日: 2023年10月20日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

がん関連製品・サービスの市場成長は、世界のがん罹患率の増加の影響を強く受けています。

2022年、米国では新たにがんと診断される患者が約190万人に上ると推定され、この病気が国内の個人や地域社会に与える影響の大きさが強調されています。さらに、同年のがん関連死は60万9,360人に上ると予測されています。がんに対する意識の高まりは、医学研究の進歩や新しい治療法の開発と相まって、市場の成長にさらに寄与しています。世界各国の政府は、早期死亡の主な原因であるがんに対処する緊急の必要性を認識しており、がん死亡率の減少を目指した取り組みやプログラムへの投資の増加につながっています。

がんの有病率の増加、意識の高まり、治療法の進歩、医学研究への投資拡大など、これらの要因が相まって、がん関連製品・サービスの市場成長が促進されています。世界のがんとの闘いの激化に伴い、効果的な予防、診断、治療、支持療法に対する需要の高まりに対応するため、市場は拡大する見通しです。

さらに、世界のヘルスケア支出の増加が予測されることから、世界のフェンタニル市場の拡大が見込まれます。業界の専門家によると、2019年の世界の1人当たりの平均総医療費は約1,129米ドルでした。この数字は、2050年までに1,515米ドルに成長すると推定されています。ヘルスケア支出の増加は、医療治療や医薬品への資源配分の増加を意味し、これがフェンタニル市場の成長に寄与する可能性が高いです。さらに、フェンタニルの治療上の利点に焦点を当てた啓発キャンペーンの実施は、予測期間中の市場拡大の可能性をさらに高めると予想されます。これらのキャンペーンは、疼痛管理と患者の転帰改善におけるフェンタニルの適切かつ責任ある使用について、ヘルスケア専門家と一般市民を教育することを目的としています。フェンタニルの安全かつ効果的な使用に関する認識を高めることで、こうした取り組みが同製品の需要を刺激し、市場の成長を促進する可能性があります。

フェンタニルの世界市場調査において考慮した主な地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。2030年末までに、北米のフェンタニル市場が最大の市場シェアを獲得すると予測されています。この地域の優位性は、人口増加、調査活動、さまざまながん診断に対する健康保険の適用可能性など、いくつかの要因に起因しています。この地域の人口増加は、フェンタニルの使用を含む医療処置のためのより多くの患者プールを提供します。さらに、北米には広範な研究活動が存在するため、フェンタニルを含む先進医薬品の開発と採用が促進され、市場の成長をさらに後押ししています。

北米における高度ながん治療の経済的地位の上昇と手頃な価格も、市場の拡大に寄与しています。例えば米国は、個人所得と支出の増加を目の当たりにしており、先進的な治療にアクセスする経済力を示しています。2019年、同国では新規のがん患者数とがん関連死亡者数が大幅に増加し、フェンタニルのような効果的な疼痛管理オプションに対する需要が浮き彫りになっています。さらに、北米の保険会社はがん治療に対する効率的な償還政策を提供しており、患者が先進的な治療法を選択する動機付けとなっています。このような有利な償還環境は、患者にフェンタニルやその他の先進的な治療法を選択するよう促す上で重要な役割を果たしており、この地域における市場の成長に寄与しています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の値を予測することです。本レポートは、調査対象国における産業の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 フェンタニルの世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の発展
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 フェンタニルの世界市場力学

  • フェンタニル市場の影響分析（2020-2030年）
    • 市場促進要因
      • 老年人口の増加
      • 世界のがんの流行
    • 市場の課題
      • フェンタニルの大量投与に伴う副作用
    • 市場機会
      • 研究費の増加

第4章 世界のフェンタニル市場：産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 フェンタニルの世界市場：投与経路別

  • 市場スナップショット
  • フェンタニルの世界市場：投与経路別、実績 - ポテンシャル分析
  • フェンタニルの世界市場、投与経路別、2020-2030年推定・予測
  • フェンタニルの世界市場、サブセグメント別分析
    • 舌下錠
    • バッカル錠
    • 経口フィルム
    • その他

第6章 フェンタニルの世界市場：エンドユーザー別

  • 市場スナップショット
  • フェンタニルの世界市場：エンドユーザー別、実績 - ポテンシャル分析
  • フェンタニルの世界市場、エンドユーザー別推定・予測2020-2030
  • フェンタニルの世界市場、サブセグメント分析
    • 病院
    • 腫瘍センター
    • 外科センター
    • その他

第7章 フェンタニルの世界市場、地域分析

  • 主要国
  • 主な新興国
  • フェンタニルの世界市場、地域別市場スナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州のフェンタニル市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋のフェンタニル市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのフェンタニル市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東・アフリカ

第8章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Thermo Fisher Scientific Inc.
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Boehringer Ingelheim GmbH
    • Bayer AG
    • Novartis AG
    • Sanofi-aventis Groupe
    • Abbott Laboratories
    • Merck & Co., Inc.
    • Validus Pharmaceuticals LLC
    • Teva Pharmaceutical Industries Ltd.
    • Siemens Healthcare GmbH

第9章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Fentanyl Market, report scope
  • TABLE 2. Global Fentanyl Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Fentanyl Market estimates & forecasts by Route of Administration 2020-2030 (USD Billion)
  • TABLE 4. Global Fentanyl Market estimates & forecasts by End User 2020-2030 (USD Billion)
  • TABLE 5. Global Fentanyl Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 6. Global Fentanyl Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Fentanyl Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Fentanyl Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Fentanyl Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Fentanyl Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Fentanyl Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Fentanyl Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Fentanyl Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Fentanyl Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. U.S. Fentanyl Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 17. U.S. Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. Canada Fentanyl Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 19. Canada Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. Canada Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. UK Fentanyl Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 22. UK Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. UK Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. Germany Fentanyl Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 25. Germany Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. Germany Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. France Fentanyl Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 28. France Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. France Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. Italy Fentanyl Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 31. Italy Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. Italy Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Spain Fentanyl Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 34. Spain Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Spain Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. RoE Fentanyl Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 37. RoE Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. RoE Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. China Fentanyl Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 40. China Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. China Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. India Fentanyl Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 43. India Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. India Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. Japan Fentanyl Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 46. Japan Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. Japan Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. South Korea Fentanyl Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 49. South Korea Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. South Korea Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. Australia Fentanyl Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 52. Australia Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. Australia Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. RoAPAC Fentanyl Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. Brazil Fentanyl Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 58. Brazil Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. Brazil Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Mexico Fentanyl Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 61. Mexico Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Mexico Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. RoLA Fentanyl Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 64. RoLA Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. RoLA Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. Saudi Arabia Fentanyl Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 67. South Africa Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. RoMEA Fentanyl Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Fentanyl Market
  • TABLE 70. List of primary sources, used in the study of global Fentanyl Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Fentanyl Market, research methodology
  • FIG 2. Global Fentanyl Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Fentanyl Market, key trends 2022
  • FIG 5. Global Fentanyl Market, growth prospects 2023-2030
  • FIG 6. Global Fentanyl Market, porters 5 force model
  • FIG 7. Global Fentanyl Market, pest analysis
  • FIG 8. Global Fentanyl Market, value chain analysis
  • FIG 9. Global Fentanyl Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Fentanyl Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Fentanyl Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Fentanyl Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Fentanyl Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Fentanyl Market, regional snapshot 2020 & 2030
  • FIG 15. North America Fentanyl Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Fentanyl Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Fentanyl Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Fentanyl Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Fentanyl Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

The market growth of cancer-related products and services is strongly influenced by the increasing prevalence of cancer globally. In 2022, the United States is estimated to witness approximately 1.9 million newly diagnosed cancer cases, emphasizing the significant impact of this disease on individuals and communities within the country. Additionally, it is projected that there will be 609,360 cancer-related deaths in the same year. The rising awareness of cancer, coupled with advancements in medical research and the development of new treatments, further contributes to the growth of the market. Governments worldwide are recognizing the urgent need to address cancer as a leading cause of premature death, leading to increased investment in initiatives and programs aimed at reducing cancer mortality rates.

The combination of these factors, including the increasing prevalence of cancer, heightened awareness, advancements in treatments, and greater investment in medical research, collectively drive the market growth of cancer-related products and services. As the global fight against cancer intensifies, the market is poised to expand to meet the growing demand for effective prevention, diagnosis, treatment, and supportive care.

Furthermore, the projected rise in global healthcare expenditure is anticipated to drive the expansion of the global fentanyl market. Industry experts have indicated that the average total health spending per person worldwide was approximately USD 1,129 USD in 2019. This figure is estimated to grow to USD 1,515 by 2050. The increase in healthcare spending signifies a greater allocation of resources towards medical treatments and pharmaceuticals, which is likely to contribute to the growth of the fentanyl market. Moreover, the implementation of awareness campaigns focusing on the therapeutic benefits of fentanyl is expected to further enhance the market's potential for expansion during the forecast period. These campaigns aim to educate healthcare professionals and the public about the appropriate and responsible use of fentanyl in managing pain and improving patient outcomes. By increasing awareness about the safe and effective utilization of fentanyl, these initiatives can potentially stimulate demand for the product and drive market growth.

The key regions considered for the Global Fentanyl Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. By the end of 2030, the North American fentanyl market is projected to capture the largest market share. This dominance in the region can be attributed to several factors, including population growth, research activities, and the availability of health insurance coverage for various cancer diagnoses. The region's growing population provides a larger patient pool for medical treatments, including fentanyl usage. Additionally, the presence of extensive research activities in North America supports the development and adoption of advanced pharmaceuticals, including fentanyl, further driving market growth.

The rising economic status and affordability of advanced cancer treatments in North America also contribute to market expansion. The United States, for instance, witnessed an increase in personal income and spending, indicating the financial capacity to access advanced treatments. In 2019, the country reported a significant number of new cancer cases and cancer-related deaths, underlining the demand for effective pain management options such as fentanyl. Furthermore, insurance companies in North America offer efficient reimbursement policies for cancer treatments, incentivizing patients to opt for advanced treatment methods. This favorable reimbursement environment plays a significant role in encouraging patients to choose fentanyl and other advanced therapies, thus contributing to the market's growth in the region.

Major market player included in this report are:

  • Thermo Fisher Scientific Inc.
  • Boehringer Ingelheim GmbH
  • Bayer AG
  • Novartis AG
  • Sanofi-aventis Groupe
  • Abbott Laboratories
  • Merck & Co., Inc.
  • Validus Pharmaceuticals LLC
  • Teva Pharmaceutical Industries Ltd.
  • Siemens Healthcare GmbH

Global Fentanyl Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Route of administration, Enduse and Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Route of Administration:

  • Sublingual Tablet
  • Buccal Tablet
  • Oral Film
  • Others

By Enduse:

  • Hospital
  • Oncology Centers
  • Surgical Centers
  • Others

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Fentanyl Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Fentanyl Market, by Route of Administration, 2020-2030 (USD Billion)
    • 1.2.3. Fentanyl Market, by End User, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Fentanyl Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Fentanyl Market Dynamics

  • 3.1. Fentanyl Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing Geriatric Population
      • 3.1.1.2. Worldwide Prevalence of Cancer
    • 3.1.2. Market Challenges
      • 3.1.2.1. Side effects associated with a high dose of fentanyl
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rise in Research Spending

Chapter 4. Global Fentanyl Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Fentanyl Market, by Route of Administration

  • 5.1. Market Snapshot
  • 5.2. Global Fentanyl Market by Route of Administration, Performance - Potential Analysis
  • 5.3. Global Fentanyl Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
  • 5.4. Fentanyl Market, Sub Segment Analysis
    • 5.4.1. Sublingual Tablet
    • 5.4.2. Buccal Tablet
    • 5.4.3. Oral Film
    • 5.4.4. Others

Chapter 6. Global Fentanyl Market, by End User

  • 6.1. Market Snapshot
  • 6.2. Global Fentanyl Market by End User, Performance - Potential Analysis
  • 6.3. Global Fentanyl Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
  • 6.4. Fentanyl Market, Sub Segment Analysis
    • 6.4.1. Hospital
    • 6.4.2. Oncology Centres
    • 6.4.3. Surgical Centres
    • 6.4.4. Others

Chapter 7. Global Fentanyl Market, Regional Analysis

  • 7.1. Top Leading Countries
  • 7.2. Top Emerging Countries
  • 7.3. Fentanyl Market, Regional Market Snapshot
  • 7.4. North America Fentanyl Market
    • 7.4.1. U.S. Fentanyl Market
      • 7.4.1.1. Route of Administration breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2. End User breakdown estimates & forecasts, 2020-2030
    • 7.4.2. Canada Fentanyl Market
  • 7.5. Europe Fentanyl Market Snapshot
    • 7.5.1. U.K. Fentanyl Market
    • 7.5.2. Germany Fentanyl Market
    • 7.5.3. France Fentanyl Market
    • 7.5.4. Spain Fentanyl Market
    • 7.5.5. Italy Fentanyl Market
    • 7.5.6. Rest of Europe Fentanyl Market
  • 7.6. Asia-Pacific Fentanyl Market Snapshot
    • 7.6.1. China Fentanyl Market
    • 7.6.2. India Fentanyl Market
    • 7.6.3. Japan Fentanyl Market
    • 7.6.4. Australia Fentanyl Market
    • 7.6.5. South Korea Fentanyl Market
    • 7.6.6. Rest of Asia Pacific Fentanyl Market
  • 7.7. Latin America Fentanyl Market Snapshot
    • 7.7.1. Brazil Fentanyl Market
    • 7.7.2. Mexico Fentanyl Market
  • 7.8. Middle East & Africa Fentanyl Market
    • 7.8.1. Saudi Arabia Fentanyl Market
    • 7.8.2. South Africa Fentanyl Market
    • 7.8.3. Rest of Middle East & Africa Fentanyl Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Company 1
    • 8.1.2. Company 2
    • 8.1.3. Company 3
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Thermo Fisher Scientific Inc.
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Recent Developments
    • 8.3.2. Boehringer Ingelheim GmbH
    • 8.3.3. Bayer AG
    • 8.3.4. Novartis AG
    • 8.3.5. Sanofi-aventis Groupe
    • 8.3.6. Abbott Laboratories
    • 8.3.7. Merck & Co., Inc.
    • 8.3.8. Validus Pharmaceuticals LLC
    • 8.3.9. Teva Pharmaceutical Industries Ltd.
    • 8.3.10. Siemens Healthcare GmbH

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption